Filing Flows › Comparisons › GOSS vs ETST
Gossamer Bio vs Earth Science Tech: GOSS and ETST compared
Gossamer Bio is the larger company: $9.2M of revenue in its latest quarter (Q2 2026) against $9.0M for Earth Science Tech (Q1 FY27). Earth Science Tech is growing faster (+3% against -20% a year earlier). Earth Science Tech is more profitable, with an operating margin of 10.6% against -282.2%.
Where the money goes: GOSS and ETST
Gossamer Bio (GOSS) · Q2 2026
Gossamer Bio, Q2 2026: revenue $9.2M (-20% year over year), operating margin -282.2%, net earnings $16.9M, operating cash flow −$39.4M. The chart follows the revenue to costs, profit and cash.
Earth Science Tech (ETST) · Q1 FY27
Earth Science Tech, Q1 FY27: revenue $9.0M (+3% year over year), operating margin 10.6%, net earnings $716K, operating cash flow $707K. The chart follows the revenue to costs, profit and cash.
| Gossamer Bio (GOSS) | Earth Science Tech (ETST) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q1 FY27 |
| Revenue | $9.2M | $9.0M |
| Revenue growth, Y/Y | -20% | +3% |
| Gross margin | — | 69.5% |
| Operating margin | -282.2% | 10.6% |
| Net earnings | $16.9M | $716K |
| Net margin | 182.9% | 7.9% |
| Operating cash flow | −$39.4M | $707K |
| Free cash flow | — | $666K |
Where the revenue comes from
Earth Science Tech
- Sale of Pharmaceutical Products and Medical Consultations: $9.0M (100%)
- Other Revenue: $31K (0%)
Questions
Which is bigger, Gossamer Bio or Earth Science Tech?
Gossamer Bio is the larger company: $9.2M of revenue in its latest quarter (Q2 2026) against $9.0M for Earth Science Tech (Q1 FY27).
Is Gossamer Bio or Earth Science Tech growing faster?
Earth Science Tech is growing faster (+3% against -20% a year earlier).
Which is more profitable, Gossamer Bio or Earth Science Tech?
Earth Science Tech is more profitable, with an operating margin of 10.6% against -282.2%.
More: Gossamer Bio earnings · how Gossamer Bio makes money · Earth Science Tech earnings · how Earth Science Tech makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Aug 7, 2026). Fiscal quarters can end on different dates. Not investment advice.